SEC 13F Intelligence

Managers / Q2 2024 · view latest →

Privium Fund Management B.V.

CIK 0001795097 · GUSTAV MAHLERPLEIN 3, AMSTERDAM, P7, 1082 MS · 31 20 462 6644

Reported Value
$392M
Q2 2024
Positions
129
Filings on Record
20
2019–present window
Filed
Aug 1, 2024
original filing

Summary

Privium Fund Management B.V. reported $392M in U.S.-listed holdings across 129 positions for Q2 2024.

Its largest position, TSLA, represents 12.1% of the portfolio.

Compared with Q1 2024, the fund opened 22 new positions and exited 10.

Portfolio Metrics

Turnover
+10.0%
vs prior filed quarter
Top-10 Concentration
+60.2%
share of reported value
Largest Position
+12.1%
Tesla
New / Exited
22 / 10
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $504MQ4 ’21Q1 ’22: $452MQ2 ’22: $302MQ3 ’22: $275MQ3 ’22Q4 ’22: $264MQ1 ’23: $298MQ2 ’23: $347MQ2 ’23Q3 ’23: $336MQ4 ’23: $359MQ1 ’24: $374MQ1 ’24Q2 ’24: $392MQ3 ’24: $402MQ4 ’24: $442MQ4 ’24Q1 ’25: $384MQ2 ’25: $464MQ3 ’25: $556MQ3 ’25Q4 ’25: $543MQ1 ’26: $480Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 68.4%Other: 20.3%Equity WRT: 5.6%ADR: 5.4%US DOMESTIC: 0.2%
  • Common Stock · 68.4% · $268M
  • Other · 20.3% · $80M
  • Equity WRT · 5.6% · $22M
  • ADR · 5.4% · $21M
  • US DOMESTIC · 0.2% · $933,750

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
AST SPACEMOBILE INCNEW+1.03M1.03M+$4M$4M
ALXOALX ONCOLOGY HLDGS INCNEW+397.0K397.0K+$2M$2M
DYNDYNE THERAPEUTICS INCNEW+14.0K14.0K+$485,654$485,654
RXRXRECURSION PHARMACEUTICALS INNEW+52.0K52.0K+$372,320$372,320
AZEKAZEK CO INCNEW+8.6K8.6K+$358,018$358,018
SA2DSANDRIDGE ENERGY INCNEW+23.3K23.3K+$299,405$299,405
NEXTNAV INCNEW+92.7K92.7K+$287,370$287,370
ZMZOOM VIDEO COMMUNICATIONS INNEW+4.9K4.9K+$286,741$286,741

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TSLATESLA INChistory →COM12.09%$47M213.0K
2SPOTIFY TECHNOLOGY S ASHS12.04%$47M150.0K
3AMZNAMAZON COM INChistory →COM7.15%$28M141.0K
4SHOPSHOPIFY INChistory →CL A6.93%$27M415.0K
5OCCIDENTAL PETE CORP*W EXP 08/03/2025.13%$20M496.2K
6SNOWSNOWFLAKE INChistory →CL A4.68%$18M129.0K
7SESEA LTDhistory →SPONSORD ADS3.74%$15M210.0K
8PLTRPALANTIR TECHNOLOGIES INChistory →CL A2.93%$12M445.0K
9ISIIONIS PHARMACEUTICALS INChistory →COM2.85%$11M247.3K
10RAREULTRAGENYX PHARMACEUTICAL INhistory →COM2.63%$10M251.6K
11PROQR THRAPEUTICS N VSHS EURO2.35%$9M5.58M
12DDOGDATADOG INChistory →CL A COM2.21%$9M66.0K
13ITCIEURINTRA-CELLULAR THERAPIES INChistory →COM2.06%$8M118.0K
14GOOGLALPHABET INChistory →CAP STK CL A1.89%$7M40.0K
15ARWRARROWHEAD PHARMACEUTICALS INhistory →COM1.85%$7M286.9K
16NVDANVIDIA CORPORATIONhistory →COM1.78%$7M57.0K
17AMDADVANCED MICRO DEVICES INChistory →COM1.53%$6M37.0K
18NETCLOUDFLARE INChistory →CL A COM1.52%$6M70.0K
19CRWDCROWDSTRIKE HLDGS INChistory →CL A1.50%$6M15.0K
20AXSMAXSOME THERAPEUTICS INChistory →COM1.50%$6M74.3K
21MRKMERCK & CO INChistory →COM1.43%$6M43.8K
22ROIVANT SCIENCES LTDSHS1.30%$5M484.5K
23RCKTROCKET PHARMACEUTICALS INChistory →COM1.27%$5M251.0K
24ALNYALNYLAM PHARMACEUTICALS INChistory →COM1.22%$5M19.4K
25MSFTMICROSOFT CORPhistory →COM1.17%$5M10.0K
26CPNGCOUPANG INChistory →CL A1.08%$4M201.9K
27ZLABZAI LAB LTDADR0.96%$4M215.8K
28AST SPACEMOBILE INC*W EXP 04/06/2020.95%$4M1.03M
29MRNAMODERNA INCCOM0.69%$3M23.3K
30UNIQURE NVSHS0.65%$3M640.4K
31ACADACADIA PHARMACEUTICALS INCCOM0.60%$2M148.4K
32ALXOALX ONCOLOGY HLDGS INCCOM0.58%$2M397.0K
33HEI/AHEICO CORP NEWCL A0.54%$2M11.9K
34GRINDR INC*W EXP 11/18/2020.52%$2M701.1K
35CELLEBRITE DI LTD*W EXP 99/99/9990.46%$2M643.9K
36NUSCALE PWR CORP*W EXP 05/02/2020.43%$2M690.4K
37BIIBBIOGEN INCCOM0.41%$2M7.0K
38UAAUNDER ARMOUR INCCL A0.37%$1M226.2K
39CRISPR THERAPEUTICS AGNAMEN AKT0.37%$1M27.3K
40ABEVAMBEV SASPONSORED ADR0.33%$1M635.9K
41KRYSKRYSTAL BIOTECH INCCOM0.29%$1M6.4K
42BF/BBROWN FORMAN CORPCL B0.28%$1M25.8K
43PFEPFIZER INCCOM0.26%$1M36.1K
44FOXFOX CORPCL B COM0.25%$998,07030.9K
45BEYOND MEAT INCNOTE 3/10.24%$933,7504.50M
46IMMATICS N.V*W EXP 07/01/2020.23%$902,233295.8K
47RNAGBPAVIDITY BIOSCIENCES INCCOM0.22%$862,99022.2K
48FDMT4D MOLECULAR THERAPEUTICS INCOM0.21%$823,20040.0K
49TRVCCITIGROUP INCCOM NEW0.21%$807,07712.5K
50MEIRAGTX HLDGS PLCCOM0.20%$803,602204.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$480M60May 5, 202613F-HRchanges · EDGAR ↗
Q4 2025$543M57Feb 3, 202613F-HRchanges · EDGAR ↗
Q3 2025$556M59Nov 4, 202513F-HRchanges · EDGAR ↗
Q2 2025$464M55Jul 30, 202513F-HRchanges · EDGAR ↗
Q1 2025$384M56May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$442M64Feb 11, 202513F-HRchanges · EDGAR ↗
Q3 2024$402M82Nov 1, 202413F-HRchanges · EDGAR ↗
Q2 2024$392M129Aug 1, 202413F-HRchanges · EDGAR ↗
Q1 2024$374M117Apr 30, 202413F-HRchanges · EDGAR ↗
Q4 2023$359M114Feb 26, 2024RESTATEMENTchanges · EDGAR ↗
Q3 2023$336M115Nov 6, 202313F-HRchanges · EDGAR ↗
Q2 2023$347M124Jul 26, 2023RESTATEMENTchanges · EDGAR ↗
Q1 2023$298M126May 3, 202313F-HRchanges · EDGAR ↗
Q4 2022$264M150Feb 3, 202313F-HRchanges · EDGAR ↗
Q3 2022$275M226Nov 3, 202213F-HRchanges · EDGAR ↗
Q2 2022$302M252Jul 28, 202213F-HRchanges · EDGAR ↗
Q1 2022$452M279May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$504M253Feb 9, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.